Tenax Therapeutics (TENX) Market Capitalization (2010 - 2026)

Tenax Therapeutics has disclosed Market Capitalization across 17 years of filings, most recently posting $658.0 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 188.7% year-over-year to $658.0 million; the TTM figure through Jun 2026 stood at $658.0 million (up 188.7% YoY), while the FY2025 annual figure was $478.1 million, up 405.71% from the prior year.
• Market Capitalization came in at $658.0 million for Q2 2026 at Tenax Therapeutics, down from $723.2 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $1.6 billion in Q1 2022 to a low of $5.2 million in Q1 2024.
• Average Market Capitalization over 5 years is $400.6 million, with a median of $324.2 million recorded in 2023.
• Year-over-year, Market Capitalization plunged 98.97% in 2024 and surged 4535.8% in 2025.
• Over 5 years, Market Capitalization stood at $261.3 million in 2022, then tumbled by 97.91% to $5.5 million in 2023, then soared by 1629.5% to $94.5 million in 2024, then soared by 405.71% to $478.1 million in 2025, then soared by 37.65% to $658.0 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $658.0 million in Q2 2026, $723.2 million in Q1 2026, and $478.1 million in Q4 2025.